{
     "PMID": "21852200",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20120210",
     "LR": "20131121",
     "IS": "1525-5069 (Electronic) 1525-5050 (Linking)",
     "VI": "22",
     "IP": "2",
     "DP": "2011 Oct",
     "TI": "Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus.",
     "PG": "207-13",
     "LID": "10.1016/j.yebeh.2011.07.004 [doi]",
     "AB": "Aiming at a better understanding of the role of A(2A) in temporal lobe epilepsy (TLE), we characterized the effects of the A(2A) antagonist SCH58261 (7-(2-phenylethyl)-5-amino-2(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrim idine) on seizures and neuroprotection in the pilocarpine model. The effects of SCH58261 were further analyzed in combination with the A(1) agonist R-Pia (R(-)-N(6)-(2)-phenylisopropyl adenosine). Eight groups were studied: pilocarpine (Pilo), SCH+Pilo, R-Pia+Pilo, R-Pia+SCH+Pilo, Saline, SCH+Saline, R-Pia+Saline, and R-Pia+SCH+Saline. The administration of SCH58261, R-Pia, and R-Pia+SCH58261 prior to pilocarpine increased the latency to SE, and decreased either the incidence of or rate of mortality from SE compared with controls. Administration of R-Pia and R-Pia+SCH58261 prior to pilocarpine reduced the number of Fluoro-Jade B-stained cells in the hippocampus and piriform cortex when compared with control. This study showed that pretreatment with R-Pia and SCH58261 reduces seizure occurrence, although only R-Pia has neuroprotective properties. Further studies are needed to clarify the neuroprotective role of A(2A) in TLE.",
     "CI": [
          "Copyright (c) 2011 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Rosim, Fernanda Elisa",
          "Persike, Daniele Suzete",
          "Nehlig, Astrid",
          "Amorim, Rebeca Padrao",
          "de Oliveira, Daniela Mara",
          "Fernandes, Maria Jose da Silva"
     ],
     "AU": [
          "Rosim FE",
          "Persike DS",
          "Nehlig A",
          "Amorim RP",
          "de Oliveira DM",
          "Fernandes MJ"
     ],
     "AD": "Departamento de Neurologia e Neurocirurgia, Neurologia Experimental, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20110817",
     "PL": "United States",
     "TA": "Epilepsy Behav",
     "JT": "Epilepsy & behavior : E&B",
     "JID": "100892858",
     "RN": [
          "0",
          "(5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimi",
          "dine)",
          "0 (Fluoresceins)",
          "0 (Neuroprotective Agents)",
          "0 (Organic Chemicals)",
          "0 (Pyrimidines)",
          "0 (Receptor, Adenosine A1)",
          "0 (Receptor, Adenosine A2A)",
          "0 (Triazoles)",
          "0 (fluoro jade)",
          "01MI4Q9DI3 (Pilocarpine)",
          "29193-86-0 (Phenylisopropyladenosine)",
          "K72T3FS567 (Adenosine)"
     ],
     "SB": "IM",
     "MH": [
          "Adenosine/pharmacology",
          "Analysis of Variance",
          "Animals",
          "Brain/pathology",
          "Cell Count",
          "Disease Models, Animal",
          "Drug Interactions",
          "Fluoresceins",
          "Male",
          "Nerve Degeneration/etiology/metabolism/pathology",
          "Neuroprotective Agents/pharmacology/therapeutic use",
          "Organic Chemicals/metabolism",
          "Phenylisopropyladenosine/pharmacology/therapeutic use",
          "Pilocarpine/toxicity",
          "Pyrimidines/therapeutic use",
          "Rats",
          "Rats, Wistar",
          "Reaction Time/drug effects",
          "Receptor, Adenosine A1/*metabolism",
          "Receptor, Adenosine A2A/*metabolism",
          "Status Epilepticus/chemically induced/drug therapy/*metabolism/pathology",
          "Triazoles/therapeutic use"
     ],
     "EDAT": "2011/08/20 06:00",
     "MHDA": "2012/02/11 06:00",
     "CRDT": [
          "2011/08/20 06:00"
     ],
     "PHST": [
          "2011/05/02 00:00 [received]",
          "2011/06/16 00:00 [revised]",
          "2011/07/05 00:00 [accepted]",
          "2011/08/20 06:00 [entrez]",
          "2011/08/20 06:00 [pubmed]",
          "2012/02/11 06:00 [medline]"
     ],
     "AID": [
          "S1525-5050(11)00388-X [pii]",
          "10.1016/j.yebeh.2011.07.004 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Epilepsy Behav. 2011 Oct;22(2):207-13. doi: 10.1016/j.yebeh.2011.07.004. Epub 2011 Aug 17.",
     "term": "hippocampus"
}